Facing Addiction in America


Book Description

All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.




Pain Management and the Opioid Epidemic


Book Description

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.




An Analytic Assessment of U.S. Drug Policy


Book Description

This book concludes that AmericaOs drug policy should be reoriented in several ways to be more effective.




The American Disease


Book Description

The American Disease is a classic study of the development of drug laws in the United States. Supporting the theory that Americans' attitudes toward drugs have followed a cyclic pattern of tolerance and restraint, author David F. Musto examines the relationz between public outcry and the creation of prohibitive drug laws from the end of the Civil War up to the present. Originally published in 1973, and then in an expanded edition in 1987, this third edition contains a new chapter and preface that both address the renewed debate on policy and drug legislation from the end of the Reagan administration to the current Clinton administration. Here, Musto thoroughly investigates how our nation has dealt with such issues as the controversies over prevention programs and mandatory minimum sentencing, the catastrophe of the crack epidemic, the fear of a heroin revival, and the continued debate over the legalization of marijuana.




Drugs and Drug Policy


Book Description

While there have always been norms and customs around the use of drugs, explicit public policies--regulations, taxes, and prohibitions--designed to control drug abuse are a more recent phenomenon. Those policies sometimes have terrible side-effects: most prominently the development of criminal enterprises dealing in forbidden (or untaxed) drugs and the use of the profits of drug-dealing to finance insurgency and terrorism. Neither a drug-free world nor a world of free drugs seems to be on offer, leaving citizens and officials to face the age-old problem: What are we going to do about drugs? In Drugs and Drug Policy, three noted authorities survey the subject with exceptional clarity, in this addition to the acclaimed series, What Everyone Needs to Know®. They begin, by defining "drugs," examining how they work in the brain, discussing the nature of addiction, and exploring the damage they do to users. The book moves on to policy, answering questions about legalization, the role of criminal prohibitions, and the relative legal tolerance for alcohol and tobacco. The authors then dissect the illicit trade, from street dealers to the flow of money to the effect of catching kingpins, and show the precise nature of the relationship between drugs and crime. They examine treatment, both its effectiveness and the role of public policy, and discuss the beneficial effects of some abusable substances. Finally they move outward to look at the role of drugs in our foreign policy, their relationship to terrorism, and the ugly politics that surround the issue. Crisp, clear, and comprehensive, this is a handy and up-to-date overview of one of the most pressing topics in today's world. What Everyone Needs to Know® is a registered trademark of Oxford University Press.




Drugs and Democracy in Latin America


Book Description

While the U.S. has failed to reduce the supply of cocaine and heroin entering its borders, it has, however, succeeded in generating widespread, often profoundly damaging, consequences on democracy and human rights in Latin America and the Caribbean.




Drugs and Drug Policy in America


Book Description

Court cases, speeches, laws, opinion pieces, and other documents bring to life the controversies surrounding the issues. Explanatory introductions to documents aid users in understanding the various arguments put forth while illuminating the significance of each document."--BOOK JACKET.




Drug Abuse and Social Policy in America


Book Description

Illicit drugs, despite the “war” waged by the United States government, remain a tremendous drain on the American economy and continue to take their toll on the lives of countless Americans. A comprehensive text with an instructor's manual, Drug Abuse and Social Policy in America analyzes why current US policy on the use of licit and illicit mood-altering drugs has failed. This groundbreaking book addresses differences between decriminalization, legalization, and “zero tolerance”--areas and philosophies that are poorly understood--and suggests a multipronged approach to diminish inappropriate drug use. Physicians, health care providers, teachers, law enforcement officers, policymakers, social service providers, and students of public policy and health will gain a better understanding of substance abuse as a societal problem, rather than an individual problem, and see that the billions of dollars spent on law enforcement would be better spent on education, prevention, treatment, and providing alternatives to drug use.Currently the leading risk factor associated with the transmission of HIV, illicit drugs continue to destroy the fabric of life in many inner-city communities. Yet, drugs are a problem for Americans from every corner of society, from suburban teenagers to pro athletes to homeless people. Author Barry Stimmel demonstrates in Drug Abuse and Social Policy in America that the drug problem is not being addressed adequately because of a lack of commitment from the majority of Americans and government leaders. The issues Drug Abuse and Social Policy in America asks readers to confront include: Why do we provide insufficient treatment facilities and incarcerate users, yet wonder why more prison space is needed? Why do we readily agree to build more prisons rather than community centers that provide alternatives for youths? Why are we concerned with teenage smoking and drinking, yet allow advertising of these substances? Why do we advocate rehabilitation, but not hire people in recovery? Why do we ask pregnant women with drug problems to seek help, then try to take custody of their children rather than provide social support while they receive treatment?Drug Abuse and Social Policy in America challenges academics, practitioners, and future social service providers and policymakers to rethink their entire conception of the problem of substance abuse in America with a cutting question: “Have we made any substantial progress in diminishing the sue of nicotine, the excessive consumption of alcohol, or the inappropriate use of prescription drugs, all of which are responsible for more illnesses and societal costs than all illicit drugs combined?” Identifying this as the place where all efforts to curb drug use must start, Drug Abuse and Social Policy in America offers readers many ways that individuals, communities, organizations, and society can take action and be more effective in convincing both those who consume drugs and those who profit from their sale that their actions are inappropriate and unacceptable.




Treating Drug Problems:


Book Description

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.




White Market Drugs


Book Description

The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer’s Heroin to Purdue’s OxyContin and all the drugs in between: barbiturate “goof balls,” amphetamine “thrill pills,” the “love drug” Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls “white markets,” where legal drugs called medicines are sold to a largely white clientele. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its “drug wars”—until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America’s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself—ideas that have been failing us catastrophically for over a century.